Preclinical Explorative Assessment of Dimethyl Fumarate-Based Biocompatible Nanolipoidal Carriers for the Management of Multiple Sclerosis-Reference-Cited by-同舟云学术

Preclinical Explorative Assessment of Dimethyl Fumarate-Based Biocompatible Nanolipoidal Carriers for the Management of Multiple Sclerosis

Published:2018-01-22 Issue:5 Volume:9 Page:1152-1158
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Kumar Pramod¹,Sharma Gajanand²,Gupta Varun³,Kaur Ramanpreet⁴,Thakur Kanika²,Malik Ruchi¹,Kumar Anil³,Kaushal Naveen⁴,Raza Kaisar¹^ORCID

Affiliation:

1. Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandar Sindri, Distt. Ajmer, Rajasthan, India 305817

2. Division of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India 160014

3. Pharmacology Division, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Studies (UGC-CAS), Panjab University, Chandigarh, India 160014

4. Department of Biophysics, Panjab University, Chandigarh, India 160014

Funder

University Grants Commission

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.7b00519

Reference33 articles.

1. WHO Mortality Database. http://www.who.int/healthinfo/mortality_data/en/ (accessed 07/01/2018).

2. Multiple sclerosis in India: An overview